KD Logo

Insider AFEYAN NOUBAR sells 15,000 of Moderna Inc [MRNA] Stock

Moderna Inc’s filing revealed that its Director AFEYAN NOUBAR unloaded Company’s shares for reported $1.91 million on Jun 26 ’24. In the deal valued at $127.22 per share,15,000 shares were sold. As a result of this transaction, AFEYAN NOUBAR now holds 2,284,015 shares worth roughly $267.39 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, AFEYAN NOUBAR sold 15,000 shares, generating $2,003,561 in total proceeds. Upon selling the shares at $133.57, the Director now owns 2,299,015 shares.

Before that, Hoge Stephen sold 15,000 shares. Moderna Inc shares valued at $2,072,400 were divested by the President at a price of $138.16 per share. As a result of the transaction, Hoge Stephen now holds 1,457,089 shares, worth roughly $170.58 million.

HSBC Securities downgraded its Moderna Inc [MRNA] rating to a Reduce from a a Hold in a research note published on February 26, 2024; the price target was increased to $86 from $75. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in early January from “a Perform” to “an Outperform”. Canaccord Genuity began covering MRNA with “Hold” recommendation on November 29, 2023. HSBC Securities revised its rating on November 03, 2023. It rated MRNA as “a Hold” which previously was an “a Reduce”.

Price Performance Review of MRNA

On Tuesday, Moderna Inc [NASDAQ:MRNA] saw its stock jump 0.97% to $117.07. Over the last five days, the stock has lost -14.92%. Moderna Inc shares have risen nearly 17.72% since the year began. Nevertheless, the stocks have fallen -3.65% over the past one year. While a 52-week high of $170.47 was reached on 05/24/24, a 52-week low of $62.55 was recorded on 02/13/24. SMA at 50 days reached $132.79, while 200 days put it at $103.91. A total of 3.41 million shares were traded, compared to the trading of 3.98 million shares in the previous session.

Levels Of Support And Resistance For MRNA Stock

The 24-hour chart illustrates a support level at 114.35, which if violated will result in even more drops to 111.62. On the upside, there is a resistance level at 119.47. A further resistance level may holdings at 121.86. The Relative Strength Index (RSI) on the 14-day chart is 32.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -14.31, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.69%. Stochastics%K at 4.23% indicates the stock is a buying.

Most Popular